Which has the lower trailing P/E, BMY or CVS?

BMY has the lower trailing P/E: BMY trades at 17.57 and CVS at 47.17. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or CVS?

Over the past five years, CVS grew revenue faster — BMY at a 2.52% CAGR versus CVS at 8.52%.

Does BMY or CVS pay a bigger dividend?

BMY yields 4.00% and CVS yields 2.48% based on trailing dividends and the latest price.

Is BMY or CVS more profitable?

BMY runs the higher net margin — BMY at 15.01% versus CVS at 0.72%.

How have BMY and CVS total returns compared?

Over the past 10 years, BMY delivered 2.02% and CVS delivered 4.62% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs CVS Health Corp. (CVS)

A side-by-side comparison of Bristol-Myers Squibb Company and CVS Health Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$129.88B

$63.60HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

CVS

CVS Health Corp.

$139.51B

$109.34HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — BMY vs CVS

growth of $100 · dividends reinvested · last 30y

BMY +735.9%CVS +1692.7%CVS compounded faster

BMY CVS

BMY vs CVS: by the numbers

•CVS is the larger company ($139.51B vs $129.88B market cap).
•BMY trades at the lower trailing earnings multiple (17.57 vs 47.17 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (15.01% vs 0.72% net margin).
•CVS grew revenue faster over the past five years (8.52% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.00% vs 2.48%).

Metrics side by side

Valuation

Metric	BMY	CVS
P/E ratio	17.57	47.17
Forward P/E	9.86	14.37
P/S ratio	2.64	0.34
P/B ratio	6.37	1.77
PEG ratio	1.87	N/A
EV / EBITDA	10.34	19.53
FCF yield	9.31%	5.40%

Profitability

Metric	BMY	CVS
Gross margin	68.75%	13.87%
Operating margin	25.67%	1.46%
Net margin	15.01%	0.72%
ROE	36.25%	3.79%
ROIC	13.90%	4.72%

Dividends

Metric	BMY	CVS
Dividend yield	4.00%	2.48%
Payout ratio	72.25%	190.00%

Growth (annualized)

Metric	BMY	CVS
Revenue CAGR (5Y)	2.52%	8.52%
EPS CAGR (5Y)	9.38%	-23.89%
FCF CAGR (5Y)	-2.50%	-10.57%
Total return CAGR (5Y)	2.73%	8.59%

Frequently asked

Which has the lower trailing P/E, BMY or CVS?: BMY has the lower trailing P/E: BMY trades at 17.57 and CVS at 47.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or CVS?: Over the past five years, CVS grew revenue faster — BMY at a 2.52% CAGR versus CVS at 8.52%.
Does BMY or CVS pay a bigger dividend?: BMY yields 4.00% and CVS yields 2.48% based on trailing dividends and the latest price.
Is BMY or CVS more profitable?: BMY runs the higher net margin — BMY at 15.01% versus CVS at 0.72%.
How have BMY and CVS total returns compared?: Over the past 10 years, BMY delivered 2.02% and CVS delivered 4.62% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full CVS analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio CVS Health P/E ratio Bristol-Myers Squibb dividend yield CVS Health dividend yield Bristol-Myers Squibb ROE CVS Health ROE Bristol-Myers Squibb operating margin CVS Health operating margin Bristol-Myers Squibb revenue growth CVS Health revenue growth Bristol-Myers Squibb free cash flow CVS Health free cash flow

Bristol-Myers Squibb & CVS Health appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.